These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25369565)

  • 21. Interaction of a Macrocycle with an Aggregation-Prone Region of a Monoclonal Antibody.
    Martinez Morales M; Zalar M; Sonzini S; Golovanov AP; van der Walle CF; Derrick JP
    Mol Pharm; 2019 Jul; 16(7):3100-3108. PubMed ID: 31088082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDs as solubilizers: effects of excipients and competing drugs.
    Jansook P; Loftsson T
    Int J Pharm; 2009 Sep; 379(1):32-40. PubMed ID: 19524652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The delivery of triamterene by cucurbit[7]uril: synthesis, structures and pharmacokinetics study.
    Ma WJ; Chen JM; Jiang L; Yao J; Lu TB
    Mol Pharm; 2013 Dec; 10(12):4698-705. PubMed ID: 24188081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyclic cucurbit[n]uril congeners are high affinity hosts.
    Ma D; Zavalij PY; Isaacs L
    J Org Chem; 2010 Jul; 75(14):4786-95. PubMed ID: 20540586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro selectivity of an acyclic cucurbit[n]uril molecular container towards neuromuscular blocking agents relative to commonly used drugs.
    Ganapati S; Zavalij PY; Eikermann M; Isaacs L
    Org Biomol Chem; 2016 Jan; 14(4):1277-87. PubMed ID: 26648135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of (SBE)7m-beta-CD and HP-beta-CD on the stability of two anti-neoplastic agents, melphalan and carmustine.
    Ma DQ; Rajewski RA; Vander Velde D; Stella VJ
    J Pharm Sci; 2000 Feb; 89(2):275-87. PubMed ID: 10688757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host-Guest Complexation by β-Cyclodextrin Enhances the Solubility of an Esterified Protein.
    Cheah KM; Jun JV; Wittrup KD; Raines RT
    Mol Pharm; 2022 Nov; 19(11):3869-3876. PubMed ID: 36036888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of various processes for simultaneous complexation and granulation to incorporate drug-cyclodextrin complexes into solid dosage forms.
    Gyanani V; Siddalingappa B; Betageri GV
    Drug Dev Ind Pharm; 2015; 41(11):1856-63. PubMed ID: 25754112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients.
    Kuok KI; Li S; Wyman IW; Wang R
    Ann N Y Acad Sci; 2017 Jun; 1398(1):108-119. PubMed ID: 28692768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentially functionalized acyclic cucurbiturils: synthesis, self-assembly and CB[6]-induced allosteric guest binding.
    Zhang M; Sigwalt D; Isaacs L
    Chem Commun (Camb); 2015 Oct; 51(78):14620-3. PubMed ID: 26288859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
    Thompson DO
    Crit Rev Ther Drug Carrier Syst; 1997; 14(1):1-104. PubMed ID: 9043816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement on solubility of fluticasone propionate with cyclodextrins by mechanochemical activation.
    Dai J; Liang X; Su W
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):799-806. PubMed ID: 25796157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance.
    Rodriguez-Aller M; Guinchard S; Guillarme D; Pupier M; Jeannerat D; Rivara-Minten E; Veuthey JL; Gurny R
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):203-14. PubMed ID: 25960331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
    Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
    Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Recognition Properties of Enantiomerically Pure Acyclic Cucurbit[n]uril-Type Molecular Containers.
    Lu X; Isaacs L
    Org Lett; 2015 Aug; 17(16):4038-41. PubMed ID: 26251172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.